SEC Form 4 · accession 0001179110-18-005308
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jaime Contreras
Officer — Senior Vice President
Period of report
Mar 31, 2018
Accepted (ET)
Apr 3, 2018 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF3,F4 | Mar 31, 2018 | A | 1,376 | $0.00 | A | 3,786 | I | By Spouse |
| Common shares without par valueF4 | Mar 31, 2018 | F | 342 | $59.92 | D | 3,444 | I | By Spouse |
| Common shares without par value | holding | — | — | — | 50,436 | D | ||
| Common shares without par valueF1 | holding | — | — | — | 22 | I | Profit Sharing Trust | |
| Common shares without par valueF2 | holding | — | — | — | 64,297 | I | Jaime Contreras Marvan 2006 Living Trust | |
| Common shares without par valueF5 | holding | — | — | — | 12,081 | I | Living Trust (by spouse) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of April 2, 2018.
- F2Held in the Jaime Contreras Marvan 2006 Living Trust. The reporting person is sole trustee of the trust. The trust is revocable.
- F3This grant represents a restricted stock unit award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting on each anniversary of the grant date. The award includes the right to have stock withheld for tax purposes.
- F4The reporting person disclaims beneficial ownership of all securities held by his spouse.
- F5Held in spouse's living trust. The reporting person's spouse is sole trustee of the trust. The trust is revocable. The reporting person disclaims beneficial ownership of these securities.